Objective Gastric cancer (GC) is one of the most common malignant tumors in the world, and
its incidence rate ranks the fourth in the world. Hyperfibrinogenemia and …

Purpose Fibrinogen and platelets have been reported to play important roles in
tumorigenesis and cancer progression. The aim of this research was to investigate the …

Background Platelet and blood coagulation abnormalities frequently occur in cancer
patients. Fibrinogen is an important hemostatic factor that regulates the hemostatic pathway …

Purpose Hyperfibrinogenemia is associated with poor prognosis in various cancers;
however, its clinical relevance in gastric cancer has not been well analyzed. We conducted …

Background Abnormal hemostasis in cancer patients has previously been described,
however the correlation between the plasma fibrinogen level and cancer metastasis and …

Background: Increasing evidence has revealed that plasma fibrinogen may serve as a
prognostic indicator in multiple malignancies. However, there have been some conflicting …

Objective To investigate the association between preoperative plasma fibrinogen level and
overall survival (OS) in a cohort of Chinese gastric cancer patients who underwent …

Background Thrombocytosis in patients with cancer is reportedly associated with an
increased expression of angiogenic factors and a poor prognosis in some cancer types. The …

Background Hypercoagulation is associated with tumor progression and metastasis in
various types of malignancy. We compared the prognostic value of preoperative plasma …

Certain patients with early gastric cancer succumb to recurrent disease and cancer‑
associated complications. The key cause of recurrence is challenging to determine, since …